In summary, signaling and functional assays in CRC cell lines showed that PDGF-BB–mediated PDGFRβ activation remodels the secretome of tumor-associated fibroblasts—especially by increasing the release of CCL5 and CXCL12—thereby promoting CRC cell proliferation and migration. The gene discussed is CCL5; the disease is neoplasm.